Sector
PharmaceuticalsOpen
₹48.18Prev. Close
₹45.95Turnover(Lac.)
₹0.47Day's High
₹48.24Day's Low
₹48.1852 Week's High
₹64.552 Week's Low
₹27.5Book Value
₹15.01Face Value
₹10Mkt Cap (₹ Cr.)
30.25P/E
126.95EPS
0.38Divi. Yield
012 Aug 2024
12:00 AM
AGM
Announcement Date: 12 Aug, 2024
4 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
9 Sep 2024
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 6.27 | 6.27 | 6.27 | 6.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2.99 | 2.11 | -1.07 | -0.91 |
Net Worth | 9.26 | 8.38 | 5.2 | 5.36 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0 | 1.56 | 4.7 | 0.76 |
yoy growth (%) | -99.94 | -66.81 | 517.42 | -99.1 |
Raw materials | 0 | -1.49 | -4.31 | -0.42 |
As % of sales | 0 | 95.54 | 91.7 | 55.85 |
Employee costs | -0.21 | -0.19 | -0.19 | -0.46 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.24 | -0.44 | -0.75 | -4.35 |
Depreciation | 0 | 0 | -0.06 | -0.63 |
Tax paid | 0 | 0 | -0.03 | -0.53 |
Working capital | -0.24 | 0.02 | -6.06 | 8.23 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -99.94 | -66.81 | 517.42 | -99.1 |
Op profit growth | -21.72 | 11.99 | -66.36 | -47.07 |
EBIT growth | -45.37 | -10.56 | -77.2 | -44.5 |
Net profit growth | -45.37 | -3,990.31 | -99.88 | -207.52 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,686.25 | 128.43 | 4,04,587.86 | 1,181.05 | 0.8 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,940.85 | 76.08 | 1,57,710.9 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,512 | 26.24 | 1,22,115.23 | 1,438.15 | 0.86 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,238 | 60.07 | 1,09,583.71 | 485 | 0.86 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,497.8 | 53.29 | 1,03,053.87 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Devendra J Shrimanker
Independent Director
Prajakta Shidhore
Non Executive Director
Arun Goenka
Non Executive Director
Purusottam Kejriwal
Company Sec. & Compli. Officer
Divya Desai
Non Executive Director
Kostuv Kejriwal
Independent Director
Haroon Hasan Siddiqi
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Pentokey Organy (India) Ltd
Summary
Pentokey Organy (India) Ltd was incorporated on November 26, 1986. The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde. Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc.In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices. Company therefore purchased the Acetic Acid from market instead of producing the same from Ethanol or Acetaldehyde. As a result of this, production of Acetaldehyde, which is an intermediate product for Acetic Acid, was low. Acetaldehyde was produced only to the extent of demand from customers. Further, Company could source Ethanol from various distilleries at competitive prices due to improved production of Sugar and Ethanol within the State of Maharashtra and so, it increased production capacity to 24000 TPA from 18000 TPA.
Read More
What is the Pentokey Organy India Ltd share price today?
The Pentokey Organy India Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹48.24 today.
What is the Market Cap of Pentokey Organy India Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Pentokey Organy India Ltd is ₹30.25 Cr. as of 12 May ‘25
What is the PE and PB ratio of Pentokey Organy India Ltd?
The PE and PB ratios of Pentokey Organy India Ltd is 126.95 and 3.21 as of 12 May ‘25
What is the 52 Week High and Low of Pentokey Organy India Ltd?
The 52-week high/low is the highest and lowest price at which a Pentokey Organy India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Pentokey Organy India Ltd is ₹27.5 and ₹64.5 as of 12 May ‘25
What is the CAGR of Pentokey Organy India Ltd?
Pentokey Organy India Ltd's CAGR for 5 Years at 52.97%, 3 Years at 51.15%, 1 Year at -1.23%, 6 Month at -2.21%, 3 Month at 19.14% and 1 Month at 34.00%.
What is the shareholding pattern of Pentokey Organy India Ltd?
The shareholding pattern of Pentokey Organy India Ltd is as follows:
Promoters - 73.03 %
Institutions - 2.31 %
Public - 24.66 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
